Related Experiment Video
Updated: Sep 30, 2025

12:50
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
6.7K
Immunomodulation by endothelial cells - partnering up with the immune system?
Jacob Amersfoort1, Guy Eelen1, Peter Carmeliet2,3,4
1Laboratory of Angiogenesis and Vascular Metabolism, VIB and Department of Oncology, KU Leuven, Leuven, Belgium.
Nature Reviews. Immunology
|March 15, 2022
Summary
Endothelial cells (ECs) in blood vessels have specific immunomodulatory roles. Researchers propose these
Area of Science:
- Immunology and Vascular Biology
Background:
- Blood vessel endothelial cells (ECs) are known to regulate immune cell trafficking and function, influencing inflammation.
- The immunomodulatory capacity of heterogeneous EC populations across different tissues remains under-explored.
- Recent single-cell studies reveal EC subtypes with distinct immune-related gene signatures.
Purpose of the Study:
- To explore the tissue-specific and vessel type-specific immunomodulatory roles of distinct EC subtypes.
- To highlight the potential of these 'immunomodulatory ECs' (IMECs) in immunotherapy.
Main Methods:
- Review of recent single-cell studies identifying EC subtypes.
- Analysis of gene expression patterns related to immune functions (phagocytosis, antigen presentation, immune cell recruitment).
- Discussion of emerging evidence on tissue-specific EC functions.
Main Results:
- Identification of specific EC subtypes with specialized immune functions.
- Evidence suggests a heterogeneous and context-dependent immunomodulatory capacity of ECs.
- These specialized ECs, termed 'immunomodulatory ECs' (IMECs), exhibit unique immune-related gene signatures.
Conclusions:
- Distinct EC subtypes possess significant, tissue-specific immunomodulatory functions.
- These 'immunomodulatory ECs' (IMECs) play a more critical role in immunity than previously understood.
- IMECs represent promising novel targets for developing innovative immunotherapeutic strategies.
Related Concept Videos
Tumor Immunotherapy
702
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
702
Cell-mediated Immune Responses
74.6K
Overview
74.6K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Immunoglobulin-like Cell Adhesion Molecules
3.5K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.5K
Cytotoxic T Cells-mediated Immune Response
3.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
3.2K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K

